Geode Capital Management, LLC Longeveron Inc. Transaction History

Geode Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$1.25 - $2.51 $20,961 - $42,090	16,769 Added 22.82%	90,238 $122,000
Q3 2023 Nov 13, 2023	BUY	$2.15 - $3.59 $15,215 - $25,406	7,077 Added 10.66%	73,469 $171,000
Q2 2023 Aug 11, 2023	BUY	$2.52 - $4.0 $73,614 - $116,848	29,212 Added 78.57%	66,392 $224,000
Q4 2022 Feb 13, 2023	BUY	$2.81 - $39.7 $4,108 - $58,041	1,462 Added 4.09%	37,180 $119,000
Q2 2022 Aug 12, 2022	BUY	$5.93 - $15.61 $10,573 - $27,832	1,783 Added 5.25%	35,718 $211,000
Q1 2022 May 13, 2022	BUY	$5.06 - $13.8 $33,628 - $91,714	6,646 Added 24.35%	33,935 $468,000
Q4 2021 Feb 11, 2022	BUY	$2.92 - $42.3 $16,816 - $243,605	5,759 Added 26.75%	27,289 $329,000
Q3 2021 Nov 12, 2021	BUY	$3.4 - $8.3 $22,922 - $55,958	6,742 Added 45.59%	21,530 $76,000
Q2 2021 Aug 13, 2021	BUY	$5.2 - $8.13 $76,897 - $120,226	14,788 New	14,788 $120,000

581

Ticker LGVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,925,940
Market Cap $12.4M
Description
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult ...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.